Clinical Trial Update: Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating early versus delayed fludarabine and rituximab in previously untreated chronic lymphocytic leukemia; study terminated with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2020-04-06